TickerFacts.

NovaBridge Biosciences (NBP): Operating Cash Flow

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Operating Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

-1.30B CNY
Year ended 2023-12-31
433.56M CNY2017-12-31: -252.16M CNY2018-12-31: -280.70M CNY2019-12-31: -867.98M CNY2020-12-31: 433.56M CNY2021-12-31: -973.09M CNY2022-12-31: -1.10B CNY2023-12-31: -1.30B CNY-1.30B CNY
2017-12-31 Operating Cash Flow (CNY) 2023-12-31
Period endedOperating Cash FlowChange YoYSource filing
2023-12-31-1.30B CNYn/m2024-04-30, From 2023-01-01
2022-12-31-1.10B CNYn/m2024-04-30, From 2022-01-01
2021-12-31-973.09M CNYn/m2024-04-30, From 2021-01-01
2020-12-31433.56M CNYn/m2023-05-01, From 2020-01-01
2019-12-31-867.98M CNYn/m2022-04-29, From 2019-01-01
2018-12-31-280.70M CNYn/m2021-04-28, From 2018-01-01
2017-12-31-252.16M CNYn/a2020-04-29, From 2017-01-01